[1]
D. . Siegel, C. Murphy, K. Wangsness, A. . Perry, and I. . Smith, “Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma”, J of Skin, vol. 6, no. 2, pp. 109–121, Mar. 2022.